Significant Wealth Partners LLC Increases Stock Position in The Clorox Company $CLX

Significant Wealth Partners LLC lifted its stake in The Clorox Company (NYSE:CLX) by 11.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,775 shares of the company’s stock after acquiring an additional 382 shares during the period. Significant Wealth Partners LLC’s holdings in Clorox were worth $453,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after buying an additional 65,924 shares in the last quarter. Northern Trust Corp boosted its position in shares of Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after acquiring an additional 34,655 shares during the period. Invesco Ltd. grew its stake in Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after acquiring an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Clorox by 3.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after acquiring an additional 41,485 shares during the period. Finally, Hsbc Holdings PLC increased its holdings in Clorox by 118.8% during the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after acquiring an additional 589,544 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CLX. JPMorgan Chase & Co. raised their price target on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a report on Monday, September 8th. Citigroup reaffirmed a “neutral” rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. UBS Group dropped their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research note on Thursday, July 17th. Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. Finally, Wells Fargo & Company lowered their price target on Clorox from $138.00 to $130.00 and set an “equal weight” rating on the stock in a report on Friday, September 5th. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $142.18.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Stock Up 2.2%

Shares of NYSE:CLX opened at $123.00 on Thursday. The firm has a fifty day moving average of $123.74 and a 200 day moving average of $130.81. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm has a market capitalization of $15.04 billion, a PE ratio of 18.86, a price-to-earnings-growth ratio of 0.97 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.